What is CLEW?
CLEW provides advanced real-time AI analytics platforms engineered to empower healthcare providers in making more informed clinical decisions. By predicting life-threatening complications across diverse medical care settings, CLEW aims to significantly improve patient safety and outcomes. The company's solutions streamline patient care pathways, assist in navigating complex regulations, and ultimately contribute to lowering the overall cost of care. Initially proven in intensive care units (ICUs), CLEW develops sophisticated machine learning models designed to optimize clinical resources and guide healthcare professionals in anticipating patient deterioration across all care environments.
How much funding has CLEW raised?
CLEW has raised a total of $8.3M across 1 funding round:
Series A
$8.3M
Series A (2017): $8.3M with participation from Pitango Venture Capital and Rhon-Klinikum
Key Investors in CLEW
Pitango Venture Capital
Pitango Venture Capital is a prominent venture capital firm that actively partners with visionary entrepreneurs and groundbreaking companies, providing support from their early stages through to maturity. The firm operates with a strategic focus across its First, Growth, and HealthTech funds, prioritizing exceptional founding teams and aiming to deliver value-added support to foster innovation and growth.
Rhon-Klinikum
Rhön Klinikum, established in 1973, stands as one of Germany's largest healthcare providers, operating multiple hospital facilities with extensive bed capacity. The company specializes in integrated, patient-focused medical care, coordinating treatments across diverse facilities and sectors to ensure comprehensive healthcare delivery and maintain a significant presence in the German hospital industry.
What's next for CLEW?
The substantial enterprise-level backing positions CLEW for significant scaling and further development of its AI-driven healthcare solutions. With a focus on predictive analytics and improving clinical decision-making, the company is poised to expand its market reach and enhance its platform's capabilities. Future strategic initiatives will likely involve deepening its machine learning models, broadening its application across various healthcare settings beyond the ICU, and forging new partnerships to integrate its technology more seamlessly into existing healthcare infrastructures. This capital infusion is expected to accelerate CLEW's growth trajectory and solidify its role as a key innovator in health tech.
See full CLEW company page
